These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1500693)

  • 1. Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Effects of interferon treatment.
    Lega L; Vierucci A; Blumberg BS; Saracco G; Rizzetto M; Zhu M; Feitelson MA
    J Hepatol; 1992 Mar; 14(2-3):286-93. PubMed ID: 1500693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
    Horiike N; Blumberg BS; Feitelson MA
    J Infect Dis; 1991 Dec; 164(6):1104-12. PubMed ID: 1955710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic hepatitis delta virus infection: direct or indirect effect on hepatitis B virus replication?
    Farci P; Karayiannis P; Lai ME; Marongiu F; Orgiana G; Balestrieri A; Thomas HC
    J Med Virol; 1988 Nov; 26(3):279-88. PubMed ID: 3204366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.
    Battegay M; Simpson LH; Hoofnagle JH; Sallie R; Di Bisceglie AM
    J Med Virol; 1994 Dec; 44(4):389-92. PubMed ID: 7897369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
    Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
    Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.
    Weltman MD; Brotodihardjo A; Crewe EB; Farrell GC; Bilous M; Grierson JM; Liddle C
    J Viral Hepat; 1995; 2(1):39-45. PubMed ID: 7493293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of hepatitis B virus X antigen expression in chronic hepatitis B and cirrhosis].
    Huang Y; Wu G; Wang X
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):235-8. PubMed ID: 7587601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
    Shaikh S; Ram DB; Tanveer S; Talpur A
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.
    di Filippo Villa D; Cortes-Mancera F; Payares E; Montes N; de la Hoz F; Arbelaez MP; Correa G; Navas MC
    Virol J; 2015 Oct; 12():172. PubMed ID: 26497287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.
    Wagner N; Rotthauwe HW; Becker M; Dienes HP; Mertens T; Födisch HJ; Brackmann HH
    Eur J Pediatr; 1992 Feb; 151(2):90-4. PubMed ID: 1537369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.
    Pastore G; Santantonio T; Milella M; Monno L; Mariano N; Moschetta R; Pollice L
    J Hepatol; 1992 Mar; 14(2-3):221-5. PubMed ID: 1500686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis delta virus cDNA sequence from an acutely HBV-infected chimpanzee: sequence conservation in experimental animals.
    Kos T; Molijn A; van Doorn LJ; van Belkum A; Dubbeld M; Schellekens H
    J Med Virol; 1991 Aug; 34(4):268-79. PubMed ID: 1940877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.